New episode - ISAC's Living Legends in #InfectiousDiseases
A true legend in infectious diseases.
Prof. Jos van der Meer tells his story — science, stewardship, creativity.
🎧 www.buzzsprout.com/2599322/epis...
@souhakanj.bsky.social @heiman-wertheim.bsky.social @esgap.bsky.social
New in ISAC journal @ijaa-isac.bsky.social
Cefiderocol resistance is emerging even in China. This multi-centre study shows high resistance in blaNDM-carrying E. coli, driven by CirA/PBP3 mutations with no fitness cost and possible clonal spread.
@bsacandjac.bsky.social @ausantibiotics.bsky.social @sidpharm.bsky.social
🚀 ISAC Project Grants 2026 now open!
Exclusive to members of ISAC Member Societies.
Up to £15,000 for collaborative research in antimicrobial chemotherapy
🌍 Must include ≥2 countries + an LMIC partner.
Apply here: www.isac.world/funding/isac...
@heiman-wertheim.bsky.social @souhakanj.bsky.social
IJAA is seeking Associate Editors & Statistical Advisors with expertise in AI, biostats, omics, microbiome, mycobacteria, antiviral therapeutics, drug delivery & clinical trials.
📨 Apply by 2 April 2026: jian.li@monash.edu tinyurl.com/4ktmp3nk
@ijaa-isac.bsky.social @souhakanj.bsky.social
🌟 ISAC at TOP5 in Infectious Diseases
Executive Committee members Souha Kanj, Heiman Wertheim, David Jenkins, Patricia Muñoz & Marco Falcone represented ISAC at the #TOP5inID Congress in Venice
Well done to the organisers for an impactful event
@souhakanj.bsky.social @heiman-wertheim.bsky.social
📺 On demand: Vaccines, human challenge studies & their impact on #AMR
The ISAC Rapid Diagnostics & Biomarkers Group hosted a webinar chaired by Prof. Kordo Saeed on how CHIMs are accelerating vaccine development for pertussis, Salmonella & malaria
youtu.be/9agHa519MM0
@heiman-wertheim.bsky.social
🌟 TOP5 in Infectious Diseases Congress
ISAC Executive Committee member, Marco Falcone, opens the congress in Venice.
The ISAC symposium on "ROLE OF MULTIDRUG RESISTANT INFECTIONS IN THE REAL WORLD: EXPERIENCES FROM DIFFERENT SETTINGS" takes place today
#Top5ID @souhakanj.bsky.social
🌟 Ahead of the next call, we introduce our newest grant awardees
Dr Sandeep Thapa (Nepal) whose project will map the local antigenic landscape of K. pneumoniae to inform future vaccine development &strengthen surveillance of MDR strains
tinyurl.com/4fhfsz54 @bsacandjac.bsky.social
Also available on Apple Podcasts or wherever you listen to your favourite podcasts: podcasts.apple.com/gb/podcast/e...
🎙️ Living Legends in Infectious Diseases — a new podcast celebrating the pioneers shaping #infectiousdiseases, AMR, diagnostics & IPC
Ep1: Andreas Voss on MRSA surveillance, #infectionprevention & global stewardship
🎧 Listen: tinyurl.com/4xs4fhub
@souhakanj.bsky.social @heiman-wertheim.bsky.social
🎥 ICYMI: Tips from @ijaa-isac.bsky.social & @jgar-isac.bsky.social Editors on publishing strong antimicrobial research.
🔑 Integrity, clear authorship, transparent AI etc
🔑 Author support, ethics checks & APC waivers
Watch: youtu.be/xSR6JSJ3Hyg
@elsevierconnect.bsky.social @souhakanj.bsky.social
🌟 Ahead of the next Project Grants call, we introduce our newest awardees
Today’s highlight: Prof. Maya Weisser, Swiss Society for ID
The project aims to measure surgical‑site infections in rural Tanzania & determine how many are caused by MDR bacteria
tinyurl.com/4fhfsz54
The @ijaa-isac.bsky.social is seeking Associate Editors & Statistical Advisors with expertise in AI, biostats, omics, microbiome, mycobacteria, antiviral therapeutics, drug delivery & clinical trials.
📨 Apply by 2 April 2026
tinyurl.com/4ktmp3nk
@souhakanj.bsky.social @heiman-wertheim.bsky.social
🌟LIVE - Vaccines, human challenge studies and impact on AMR
Dr Jennifer van Heerden is giving her talk on The Malaria Challenge: the valuable role of controlled human malaria infection models (CHMIs) in malaria vaccine development
Join:
us02web.zoom.us/webinar/regi...
🌟LIVE - Vaccines, human challenge studies and impact on AMR
Dr Malick Gibani is presenting on Human Challenge Models for Salmonella to Accelerate Vaccine Development.
Join and ask your questions to the exprts:
us02web.zoom.us/webinar/regi...
🌟LIVE - Vaccines, human challenge studies and impact on AMR
Dr Adam Dale is the first speaker, presenting on Leveraging human challenge models for pertussis vaccine development.
There's still time to join the conversation:
us02web.zoom.us/webinar/regi...
🎥 On‑demand How to Get Your Paper Published
The session shared practical guidance on publishing high‑quality antimicrobial research, with insights from @elsevierconnect.bsky.social and the Editors of @ijaa-isac.bsky.social and @jgar-isac.bsky.social
Watch now:
youtu.be/xSR6JSJ3Hyg
🌟 Ahead of the next ISAC Project Grants call, we’re introducing our newest awardees.
Today’s highlight: Dr Cybele Abad from @psmidorg
awarded for REPO‑CAP, a rapid educational and point‑of‑care intervention for community‑acquired pneumonia.
🔗https://tinyurl.com/4fhfsz54
🧪 Tomorrow
Vaccines, human challenge studies & impact on AMR
📆 11 March 2026
ISAC’s Rapid Diagnostics & Biomarkers Working Group convenes leading experts pushing vaccine science forward through controlled human infection models.
Register: us02web.zoom.us/webinar/regi...
@heiman-wertheim.bsky.social
🎤 Meet Dr Jennifer van Heerden — Oxford clinician leading malaria vaccine trials using CHMIs, including the first relapsing P. vivax model.
Register ⬇️
tinyurl.com/2jpeanhp
ICC 2026 → Manila 🇵🇭
📅 7–9 Dec
Early bird registration + abstract submissions now open!
Travel awards available for researchers under 35.
Deadline: 15 Jun
icc2026ph.org
#infectiousdiseases #ICC2026
@souhakanj.bsky.social @heiman-wertheim.bsky.social @sidpharm.bsky.social @microbesinfo.bsky.social
🎤 Meet the Speaker
#Vaccines, human challenge studies & #AMR
Dr Adam Dale is a leading researcher using controlled human infection models with N. lactamica and B. pertussis to understand immunity and drive next‑gen vaccine development.
tinyurl.com/2jpeanhp
On‑demand recording of Global Perspectives in Critical Care Infection now live 🎥
Explore key insights on diagnostics, #sepsis pathways, tropical infection challenges and the vital role of #stewardship in #ICU care 💊
Watch⬇
youtu.be/LUof6jtSH04
@souhakanj.bsky.social @heiman-wertheim.bsky.social
Vaccines, human challenge studies & AMR 🧬💉
📆 11 March 2026
Join ISAC’s Rapid Diagnostics & Biomarkers group for expert insights on pertussis, Salmonella & malaria vaccine development using controlled human infection models
🔗 tinyurl.com/2jpeanhp
@heiman-wertheim.bsky.social @souhakanj.bsky.social
Great and free tool for bacterial infection treatment
New AbxGuide Update
ISAC has released a new free, open‑access chapter: Ear, Nose & Throat Infections.
Explore the latest evidence‑based antimicrobial guidance here:
www.isac-abxguide.world/index.html
#antimicrobials #antibiotics
@heiman-wertheim.bsky.social @souhakanj.bsky.social
📢 Call for leadership
ISAC’s Anti‑Infective Pharmacology Working Group is recruiting new Sub Group Leaders across four sub groups.
A great opportunity to shape the future of anti‑infective pharmacology.
🔗 Learn more & apply: tinyurl.com/ysf2t7w38
📅 Deadline: 3 April 2026
NOW LIVE
Prof. Athanasios Tsakris, Editor‑in‑Chief of @jgar-isac.bsky.social is sharing practical tips on how to strengthen your manuscript publish in JGAR.
A great session for authors aiming to elevate their antimicrobial resistance research.
us02web.zoom.us/webinar/regi...
NOW LIVE
Prof. Jian Li, Editor‑in‑Chief of @ijaa-isac.bsky.social ISAC
is sharing practical, experience‑based strategies to improve your chances of getting published — including what high‑impact antimicrobial research looks like in today’s landscape.
us02web.zoom.us/webinar/regi...